- Home
- LGL vs ANTX Comparison
LGL vs ANTX Comparison
Compare LGL & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- ANTX
- Stock Information
- Founded
- LGL 1917
- ANTX 2017
- Country
- LGL United States
- ANTX United States
- Employees
- LGL N/A
- ANTX N/A
- Industry
- LGL Industrial Machinery/Components
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- ANTX Health Care
- Exchange
- LGL Nasdaq
- ANTX Nasdaq
- Market Cap
- LGL 38.5M
- ANTX 33.2M
- IPO Year
- LGL N/A
- ANTX 2022
- Fundamental
- Price
- LGL $7.51
- ANTX $1.10
- Analyst Decision
- LGL
- ANTX Buy
- Analyst Count
- LGL 0
- ANTX 2
- Target Price
- LGL N/A
- ANTX $2.00
- AVG Volume (30 Days)
- LGL 13.7K
- ANTX 71.5K
- Earning Date
- LGL 08-12-2025
- ANTX 08-12-2025
- Dividend Yield
- LGL N/A
- ANTX N/A
- EPS Growth
- LGL 204.51
- ANTX N/A
- EPS
- LGL 0.08
- ANTX N/A
- Revenue
- LGL $4,322,000.00
- ANTX N/A
- Revenue This Year
- LGL N/A
- ANTX N/A
- Revenue Next Year
- LGL N/A
- ANTX N/A
- P/E Ratio
- LGL $99.26
- ANTX N/A
- Revenue Growth
- LGL 20.66
- ANTX N/A
- 52 Week Low
- LGL $5.03
- ANTX $0.87
- 52 Week High
- LGL $9.74
- ANTX $2.73
- Technical
- Relative Strength Index (RSI)
- LGL 54.93
- ANTX 50.52
- Support Level
- LGL $7.52
- ANTX $1.05
- Resistance Level
- LGL $7.77
- ANTX $1.16
- Average True Range (ATR)
- LGL 0.19
- ANTX 0.03
- MACD
- LGL -0.02
- ANTX 0.01
- Stochastic Oscillator
- LGL 53.33
- ANTX 47.17
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.